Inbrija (levodopa inhalation powder – Acorda) — Cigna

Initial criteria

• Patient is currently taking carbidopa-levodopa; AND
• Patient is experiencing “off” episodes; AND
• Patient does not have asthma, chronic obstructive pulmonary disease, or other chronic underlying lung disease; AND
• Inbrija is prescribed by or in consultation with a neurologist.

Approval duration

1 year